top of page
Daniela Crandall joined Britecyte in January 2025 and is the Commercial Vice President of Orthopedic Surgery. She is a bilingual healthcare executive with over 15 years of experience driving innovation in both commercial and clinical settings. Prior to joining Britecyte, Daniela served as a consultant to various medical device companies, leveraging her expertise to support commercialization strategies. She also held leadership roles at Arthrex, Mercalis, and Level Ex, a Brainlab company, and led medical affairs for the Americas and Asia Pacific at Bioventus.
Daniela earned a BA degree in Psychology from UCLA and a MHS degree, along with a Physician Assistant certification, from Duke University.
​
bottom of page